Daniel Garcia-Fernandez
Leicester, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Identification of actionable targets using DEPArray-based sorting of pure carcinoma and stromal populations from formalin-fixed paraffin-embedded tissues followed by shallow whole-genome sequencing.
Journal: The Journal of pathology
Published: February 10, 2025
Serial Postoperative Circulating Tumor DNA Assessment Has Strong Prognostic Value During Long-Term Follow-Up in Patients With Breast Cancer.
Journal: JCO precision oncology
Published: May 01, 2024
Shallow WGS of individual CTCs identifies actionable targets for informing treatment decisions in metastatic breast cancer.
Journal: British journal of cancer
Published: October 26, 2021
Cell-free DNA analysis in current cancer clinical trials: a review.
Journal: British journal of cancer
Published: July 06, 2021
Prevalence of ctDNA in early screen-detected breast cancers using highly sensitive and specific dual molecular barcoded personalised mutation assays.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 08, 2021
Circulating Tumor DNA Profiling From Breast Cancer Screening Through to Metastatic Disease.
Journal: JCO precision oncology
Published: December 17, 2020
Longitudinal whole-exome sequencing of cell-free DNA for tracking the co-evolutionary tumor and immune evasion dynamics: longitudinal data from a single patient.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 09, 2020
Longitudinal monitoring of circulating tumour DNA improves prognostication and relapse detection in gastroesophageal adenocarcinoma.
Journal: British journal of cancer
Published: May 09, 2020
A novel hotspot specific isothermal amplification method for detection of the common PIK3CA p.H1047R breast cancer mutation.
Journal: Scientific reports
Published: September 26, 2019
Plasma cell-free DNA (cfDNA) as a predictive and prognostic marker in patients with metastatic breast cancer.
Journal: Breast cancer research : BCR
Published: July 16, 2019
Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic Recurrence.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 08, 2018
Last Updated: 09/26/2026